Search Within

Paul Marks

Formats
  1. Journal Article (121)
  2. Meeting Abstract (47)
  3. Book Section (10)
  4. Book Whole (4)
  5. Conference Paper (4)
Groups
  1. Department of Medicine (18)
  2. Center for Hematologic Malignancies (15)
  3. Solid Tumor Oncology Division (14)
  4. Surgery (13)
  5. GSK Faculty (12)
  6. Genitourinary Oncology Service (12)

More Groups

People
  1. Richard Rifkind (113)
  2. Victoria Richon (77)
  3. Lang Ngo (27)
  4. Gisela Venta-Perez (20)
  5. William Kelly (16)
  6. Weisheng Xu (13)

More People

Years
  1. 2015 (2)
  2. 2014 (2)
  3. 2013 (3)
  4. 2012 (4)
  5. 2011 (3)
  6. 2010 (6)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (35)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (19)
  3. Cancer Research (15)
  4. Blood (9)
  5. Clinical Cancer Research (9)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (48)
  2. National Academy of Sciences (35)
  3. American Society of Hematology (9)
  4. Nature Publishing Group (8)
  5. Elsevier Inc. (7)
  6. John Wiley & Sons (6)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Highly potent hybrid polar compounds (HPC) induce transformed cell to differentiate or apoptose: Targeting cell cycle regulatory proteins
    Meeting Abstract

    Marks, P. A.; Richon, V. M.; Civoli, F.; Venta-Perez, G.; Russo, P.; Rifkind, R. A.
    Anticancer Research (1997)

    Fulltext@MSK | Save
  • HMBA and related compounds induce apoptosis in human myeloma cells
    Meeting Abstract

    Siegel, D.; Tang, B.; Feinman-Siegel, R.; Teitz, T.; Richon, V.; Rifkind, R. A.; Marks, P. A.; Michaeli, J.
    Anticancer Research (1997)

    Fulltext@MSK | Save
  • Quality of life: Some implications of the advances in human genome research
    Conference Paper

    Marks, P. A.
    Plenum Press (1997)

    Fulltext@MSK | Save
  • Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells
    Journal Article

    Richon, V. M.; Russo, P.; Venta-Perez, G.; Cordon-Cardo, C.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (1997)

    Fulltext@MSK | Save
  • Cell cycle regulatory proteins are targets for induced differentiation
    Meeting Abstract

    Marks, P. A.; Richon, V. M.; Rifkind, R. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Highly potent second generation hybrid polar cytodifferentiation agents
    Meeting Abstract

    Richon, V. M.; Ngo, L.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Cell differentiation and its role in carcinogenesis and therapy
    Book Section

    Rifkind, R. A.; Michaeli, J.; Richon, V. M.; Kiyokawa, H.; Busquets, X.; Leng, L.; Marks, P. A.
    In Pusztai, L.; Lewis, C. E.; Yap, E. (Eds.) Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth (1996)

    Fulltext@MSK | Save
  • Induced differentiation, the cell cycle, and the treatment of cancer
    Journal Article

    Rifkind, R. A.; Richon, V. M.; Marks, P. A.
    Pharmacology & Therapeutics (1996)

    Fulltext@MSK | Save
  • Induced differentiation of cancer cells: Second generation potent hybrid polar compounds target cell cycle regulators
    Journal Article

    Marks, P. A.; Richon, V. M.; Rifkind, R. A.
    European Journal of Cancer Prevention (1996)

    Fulltext@MSK | Save
  • Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds
    Journal Article

    Marks, P. A.; Richon, V. M.; Rifkind, R. A.
    International Journal of Hematology (1996)

    Fulltext@MSK | Save